team size
5 - 9
funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
HQ address
Toronto, M5G 1L7, CAN
AvidBiologics is a private Canadian biotechnology company developing Antibody-Drug Conjugates (ADCs) for the treatment of cancer.

AvidBiologics and its partners engineer ADCs that are highly tumour-selective. This prevents collateral damage to normal tissues and results in safe and significantly more effective cancer treatments compared to traditional chemotherapies.

AvidBiologics was spun-out from YM BioSciences Inc (NYSE Amex: YMI) in 2011. The company holds rights to novel compounds previously engineered by YMI in collaboration with National Research Council of Canada - Biotechnology Research Institute (Montreal, Canada), and Fox Chase Cancer Centre (Philadelphia, USA).
The company concentrates on preclinical and early-stage clinical development of its proprietary compounds.
AvidBiologics is based in MaRS Incubator in Toronto, Ontario, Canada.
For more details, please visit http://www.avidbiologics.com/

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats